retatrutide peptide vs semaglutide What Is Retatrutide? Side Effects, Dosing, & Weight Loss Retatrutide vs Semaglutide – Comparison

References: [1] Metsera Reports Highly Competitive Results from Ongoing Trial of Novel, Potential OnceMonthly Injectable GLP-1 Receptor Agonist MET-097 [2] Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity [3] A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings [4] Safety, tolerability and weight reduction findings of oral amycretin: a novel amylin and glucagon-like peptide-1 receptor co-agonist, in a first-in-human study

Ros Body Program is a great fit for adults looking for legitimate, prescription-based weight-loss treatment without the friction of traditional clinics

N Engl J Med 377(3):300301

Talk to your healthcare provider about the why and when. You and your provider will want to decide when to stop tirzepatide (or taper) and when to start retatrutide